GB2439402A - Methods of sterilisation of aerosol valve components - Google Patents
Methods of sterilisation of aerosol valve components Download PDFInfo
- Publication number
- GB2439402A GB2439402A GB0624421A GB0624421A GB2439402A GB 2439402 A GB2439402 A GB 2439402A GB 0624421 A GB0624421 A GB 0624421A GB 0624421 A GB0624421 A GB 0624421A GB 2439402 A GB2439402 A GB 2439402A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sterilisation
- valve
- valve components
- radiation
- components
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000004659 sterilization and disinfection Methods 0.000 title claims abstract description 89
- 238000000034 method Methods 0.000 title claims abstract description 55
- 239000000443 aerosol Substances 0.000 title claims abstract description 14
- 230000005855 radiation Effects 0.000 claims abstract description 26
- 239000000126 substance Substances 0.000 claims abstract description 12
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims abstract description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims abstract description 3
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000007844 bleaching agent Substances 0.000 claims abstract description 3
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims abstract description 3
- 239000002245 particle Substances 0.000 claims abstract description 3
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000000463 material Substances 0.000 claims description 17
- 238000007789 sealing Methods 0.000 claims description 11
- 229920000728 polyester Polymers 0.000 claims description 7
- 239000004033 plastic Substances 0.000 claims description 6
- 229920003023 plastic Polymers 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000010894 electron beam technology Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 18
- -1 for example Chemical class 0.000 description 16
- 239000003380 propellant Substances 0.000 description 15
- 239000003814 drug Substances 0.000 description 10
- 239000012530 fluid Substances 0.000 description 8
- 239000002585 base Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 5
- 239000012298 atmosphere Substances 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 2
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 2
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229940092705 beclomethasone Drugs 0.000 description 2
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 238000002788 crimping Methods 0.000 description 2
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 239000013536 elastomeric material Substances 0.000 description 2
- 229960000676 flunisolide Drugs 0.000 description 2
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- MIXMJCQRHVAJIO-TZHJZOAOSA-N qk4dys664x Chemical compound O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O MIXMJCQRHVAJIO-TZHJZOAOSA-N 0.000 description 2
- 229960002052 salbutamol Drugs 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 229960000195 terbutaline Drugs 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- AKNNEGZIBPJZJG-MSOLQXFVSA-N (-)-noscapine Chemical compound CN1CCC2=CC=3OCOC=3C(OC)=C2[C@@H]1[C@@H]1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-MSOLQXFVSA-N 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- NDAUXUAQIAJITI-LBPRGKRZSA-N (R)-salbutamol Chemical compound CC(C)(C)NC[C@H](O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-LBPRGKRZSA-N 0.000 description 1
- YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 description 1
- BQCIDUSAKPWEOX-UHFFFAOYSA-N 1,1-Difluoroethene Chemical compound FC(F)=C BQCIDUSAKPWEOX-UHFFFAOYSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical compound O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-M 3-carboxy-2,3-dihydroxypropanoate Chemical compound OC(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-M 0.000 description 1
- ALKYHXVLJMQRLQ-UHFFFAOYSA-M 3-carboxynaphthalen-2-olate Chemical compound C1=CC=C2C=C(C([O-])=O)C(O)=CC2=C1 ALKYHXVLJMQRLQ-UHFFFAOYSA-M 0.000 description 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- RPHLQSHHTJORHI-UHFFFAOYSA-N Adrenochrome Chemical compound O=C1C(=O)C=C2N(C)CC(O)C2=C1 RPHLQSHHTJORHI-UHFFFAOYSA-N 0.000 description 1
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102400000739 Corticotropin Human genes 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 229920002943 EPDM rubber Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 102400000321 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229920000459 Nitrile rubber Polymers 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- VQDBNKDJNJQRDG-UHFFFAOYSA-N Pirbuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=N1 VQDBNKDJNJQRDG-UHFFFAOYSA-N 0.000 description 1
- 229930182556 Polyacetal Natural products 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920002253 Tannate Polymers 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- AKNNEGZIBPJZJG-UHFFFAOYSA-N alpha-noscapine Natural products CN1CCC2=CC=3OCOC=3C(OC)=C2C1C1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 229960004436 budesonide Drugs 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 229960000265 cromoglicic acid Drugs 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 229960002069 diamorphine Drugs 0.000 description 1
- ACYGYJFTZSAZKR-UHFFFAOYSA-J dicalcium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Ca+2].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O ACYGYJFTZSAZKR-UHFFFAOYSA-J 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 229950005627 embonate Drugs 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229950000206 estolate Drugs 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 229960002428 fentanyl Drugs 0.000 description 1
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 1
- XUCNUKMRBVNAPB-UHFFFAOYSA-N fluoroethene Chemical compound FC=C XUCNUKMRBVNAPB-UHFFFAOYSA-N 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 229960002714 fluticasone Drugs 0.000 description 1
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 description 1
- 229960000289 fluticasone propionate Drugs 0.000 description 1
- 229960002848 formoterol Drugs 0.000 description 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229960001067 hydrocortisone acetate Drugs 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- WVLOADHCBXTIJK-YNHQPCIGSA-N hydromorphone Chemical compound O([C@H]1C(CC[C@H]23)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O WVLOADHCBXTIJK-YNHQPCIGSA-N 0.000 description 1
- 229960001410 hydromorphone Drugs 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 229940039009 isoproterenol Drugs 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 229940099584 lactobionate Drugs 0.000 description 1
- JYTUSYBCFIZPBE-AMTLMPIISA-N lactobionic acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O JYTUSYBCFIZPBE-AMTLMPIISA-N 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- LMOINURANNBYCM-UHFFFAOYSA-N metaproterenol Chemical compound CC(C)NCC(O)C1=CC(O)=CC(O)=C1 LMOINURANNBYCM-UHFFFAOYSA-N 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- LRMHVVPPGGOAJQ-UHFFFAOYSA-N methyl nitrate Chemical compound CO[N+]([O-])=O LRMHVVPPGGOAJQ-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- PLPRGLOFPNJOTN-UHFFFAOYSA-N narcotine Natural products COc1ccc2C(OC(=O)c2c1OC)C3Cc4c(CN3C)cc5OCOc5c4OC PLPRGLOFPNJOTN-UHFFFAOYSA-N 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 229960002657 orciprenaline Drugs 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229960004624 perflexane Drugs 0.000 description 1
- ZJIJAJXFLBMLCK-UHFFFAOYSA-N perfluorohexane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F ZJIJAJXFLBMLCK-UHFFFAOYSA-N 0.000 description 1
- 229960001802 phenylephrine Drugs 0.000 description 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 229960005414 pirbuterol Drugs 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 229920000052 poly(p-xylylene) Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 229960001457 rimiterol Drugs 0.000 description 1
- IYMMESGOJVNCKV-SKDRFNHKSA-N rimiterol Chemical compound C([C@@H]1[C@@H](O)C=2C=C(O)C(O)=CC=2)CCCN1 IYMMESGOJVNCKV-SKDRFNHKSA-N 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 229960004017 salmeterol Drugs 0.000 description 1
- 229960005018 salmeterol xinafoate Drugs 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- KFVSLSTULZVNPG-UHFFFAOYSA-N terbutaline sulfate Chemical compound [O-]S([O-])(=O)=O.CC(C)(C)[NH2+]CC(O)C1=CC(O)=CC(O)=C1.CC(C)(C)[NH2+]CC(O)C1=CC(O)=CC(O)=C1 KFVSLSTULZVNPG-UHFFFAOYSA-N 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/04—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/04—Heat
- A61L2/06—Hot gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/04—Heat
- A61L2/06—Hot gas
- A61L2/07—Steam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/10—Ultraviolet radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/12—Microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/20—Gaseous substances, e.g. vapours
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/20—Gaseous substances, e.g. vapours
- A61L2/202—Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/20—Gaseous substances, e.g. vapours
- A61L2/204—Formaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/20—Gaseous substances, e.g. vapours
- A61L2/206—Ethylene oxide
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
Abstract
A method of sterilisation of valve components. The method comprises providing one or more valve components -which are suitable for use in aerosol dispensing apparatus -and subjecting at least part of the one or more valve components to sterilisation means selected from one or more of radiation sterilisation means; chemical sterilisation means; and/or heat sterilisation means. The means of sterilisation include, gamma radiation, electron beam radiation, ethylene oxide, steam, autoclave, dry-heat, ozone, bleach, glutaraldehyde, formaldehyde, ortho-phthalaldehyde, hydrogen peroxide, x-rays, subatomic particles and/or UV radiation.
Description
<p>IMPROVEMENTS IN OR RELATING TO METHODS OF STERILISATION</p>
<p>The invention relates to improvements in or relating to methods of sterilisation, in particular, methods of sterilisation of valve components.</p>
<p>Aerosol dispensing apparatus are used for dispensing a wide variety of products from mobile to viscose liquid products, powdered products and the like and typically employ a liquid propellant such as a hydro-carbon or fluoro-carbon having sufficiently high vapour pressure at normal working temperatures to propel the product through the valve. These are commonly used for dispensing pharmaceutical medicaments.</p>
<p>Conventional valves, typically metering valves, for use with pressurised dispensing containers comprise a valve stem co-axially slidable within a chamber body defining an annular metering chamber. "Inner" and "outer" annular seals, which are respectively nearer and further from the bulk storage volume of the pressurised dispensing container, are operative between the valve stem and the chamber body to seal the metering chamber therebetween. The valve stem is generally movable against the action of a spring to a dispensing position, wherein the metering chamber is isolated from the container and vented to atmosphere for the discharge of product.</p>
<p>The valve is usually held in place with respect to the container by a closure which is crimped to the container to Ihereby form the dispensing apparatus.</p>
<p>Dispensing containers are often used to dispense, amongst other products, powdered or soluble medicaments which are stored in the container, suspended or dissolved in a liquefied propellant. The medicament is dispensed from the container, on actuation of the metering valve, together with the propellant as the propellant boils off. To use a dispensing apparatus comprising a metering valve as described above, a user first shakes the pressurised dispensing container and attached metering valve to agitate the liquefied propellant and medicament. The agitation of the propellant homogenises the suspended or dissolved medicament such that the concentration of rnedicament in the liquefied propellant is substantially constant throughout the propellant volume in the bulk volume of the dispensing container. The pressurised dispensing container is then inverted such that the valve stem of the metering valve is lowermost and actuated by depressing the valve stem relative to the pressurised dispensing container. The liquefied propellant and medicament contained in the metering chamber is vented to atmosphere where it is, for example, inhaled by the user. On release of the valve stem, the spring restores the valve stem to its unactuated position, whereby the metering chamber can be re-charged with liquefied propellant and medicament from the bulk volume of liquefied propellant stored in the pressurised dispensing container.</p>
<p>Accordingly, in an aspect the invention provides a method of sterilisation of valve components comprising: providing one or more valve components, which are suitable for use in aerosol dispensing apparatus; subjecting at least part of the one or more valve components to sterilisation means selected from one or more of: radiation sterilisation means; chemical sterilisation means; or heat sterilisation means.</p>
<p>Preferably, the one or more valve components comprise a chamber body, a valve body, a valve stem, one or more seals, a gasket, a ferrule, and/or a spring.</p>
<p>Further preferably, the one or more valve components can be assembled to provide a metering valve.</p>
<p>Non-sealing components of the one or more valve components may be subjected to the sterilisation means.</p>
<p>In a preferred embodiment, the one or more valve components are made from a material comprising a plastics material and, most preferably, the one or more valve components are made from a material comprising polyester.</p>
<p>The radiation sterilisation means may be gamma radiation.</p>
<p>Alternatively, the radiation sterilisation means may be electron radiation.</p>
<p>The chemical sterilisation means may be gaseous chemical sterilisation means and, most preferred, is ethylene oxide.</p>
<p>The heat sterilisation means may be heating of the one or more valve components. In particular, the heat sterilisation means may be steam.</p>
<p>The sterilisation means may comprises one or more of an autoclave, dry-heat sterilisation, ozone, bleach, glutaraldehyde, formaldehyde, ortho-phthalaldehyde, hydrogen peroxide, x-rays, subatomic particles, and/or LJV (ultra violet) radiation.</p>
<p>The one or more valve components may be un-assembled, partially-assembled or fully-assembled prior to sterilisation.</p>
<p>Further preferably, the method comprises providing a container for subsequent location of a product to be dispensed and subjecting the container to sterilisation means.</p>
<p>The present invention also includes one or more valve components sterilised by the claimed method.</p>
<p>The present invention also includes a valve as produced by the claimed method.</p>
<p>The present invention also includes an aerosol dispensing apparatus including a valve or one or more valve components sterilised by the claimed method.</p>
<p>In a second aspect, the invention provides a method of sterilisation of an aerosol dispensing apparatus wherein the apparatus comprises: one or more valve components; and a container for storing a product to be dispensed from the aerosol dispensing apparatus; wherein the method comprises subjecting at least part of the one or more valve components, and/or container to sterilisation means selected from one or more of: radiation sterilisation means; chemical sterilisation means; or heat sterilisation means.</p>
<p>It will be understood by the person skilled in the art that the method of the present invention may be used with any valve suitable for use with aerosol dispensing apparatus. Accordingly, the metering valves disclosed herein are provided as examples of valve arrangements that may benefit from the claimed invention. However, the claimed method is equally applicable to other valve arrangements not specifically disclosed herein. For example, the method is at least applicable to non-metering valves and valve components.</p>
<p>The valve may be for use in a pharmaceutical dispensing device, such as, for example, a pulmonary, nasal, or sub-lingual delivery device. A preferred use of the valve is in a pharmaceutical metered dose aerosol inhaler device. The term pharmaceutical as used herein is intended to encompass any pharmaceutical, compound, composition, medicament, agent or product which can be delivered or administered to a human being or animal, for example pharmaceuticals, drugs, biological and medicinal products. Examples include antiallergics, analgesics, antibodies, vaccines, bronchodilators, antihistamines, therapeutic proteins and peptides, antitussives, anginal preparations, antibiotics, anti-inflammatory preparations, hormones, or sulfonamides, such as, for example, a vasoconstrictive amine, an enzyme, an alkaloid, or a steroid, including combinations of two or more thereof. In particular, examples include isoproterenol [alpha-(isopropylaminomethyl) protocatechuyl alcohol), phenylephrine, phenyipropanolamine, glucagon, insulin, DNAse, adrenochrome, trypsin, epinephrine, ephedrine, narcotine, codeine, atropine, heparin, morphine, dihydromorphinone, ergotarnine, scopolamine, rnethapyrilene, cyanocobalamin, terbutaline, rimiterol, salbutamol, flunisolide, coichicine, pirbuterol, beclomethasone, orciprenaline, fentanyl, and diamorphine, streptomycin, penicillin, procaine penicillin, tetracycline, chiorotetracycline and hydroxytetracycline, adrenocorticotropic hormone and adrenocortical hormones, such as cortisone, hydrocortisone, hydrocortisone acetate and prednisolone, insulin, cromolyn sodium, and morrietasone, including combinations of two or more thereof.</p>
<p>The pharmaceutical may be used as either the free base or as one or more salts conventional in the art, such as, for example, acetate, benzeriesulphonate, benzoate, bircarbonate, bitartrate, bromide, calcium edetate, camsylate, carbonate, chloride, citrate, dihydrochioride, edetate, edisylate, estolate, esylate, fumarate, fluceptate, gluconate, glutamate, glycollylarsanilate, hexyiresorcinate, hydrobromide, hydrochloride, hydroxynaphthoate, iodide, isethionate, lactate, lactobionate, malate, maleate, rnandelate, mesylate, methylbromide, methylnitrate, methylsuiphate, mucate, napsylate, nitrate, pamoate, (embonate), pantothenate, phosphate, diphosphate, polygalacturonate, salicylate, stearate, subacetate, succinate, sulphate, tannate, tartrate, and triethiodide, including combinations of two or more thereof. Cationic salts may also be used, for example the alkali metals, e.g. Na arid K, and ammonium salts and salts of amines known in the art to be pharmaceutically acceptable, for example glycine, ethylene diamine, choline, diethanolamine, triethanolamine, octadecylamine, diethylamine, triethylamine, l-amino-2-propanol-amino-2- (hydroxymethyl)propane-1, 3-diol, and 1-(3,4--dihydroxyphenyl) -2 isopropylarninoethanol.</p>
<p>The pharmaceutical will typically be one which is suitable for inhalation and may be provided in any suitable form for this purpose, for example as a solution or powder suspension in a solvent or carrier liquid, for example ethanol, or isopropyl alcohol. Typical propellants are HFA134a, HFA227 and di-methyl ether.</p>
<p>The pharmaceutical may, for example, be one which is suitable for the treatment of asthma. Examples include salbutamol, beclomethasone, salmeterol, fluticasone, formoterol, terbutaline, sodium chromoglycate, budesonide and flunisolide, and physiologically acceptable salts (for example salbutamol sulphate, salmeterol xinafoate, fluticasone propionate, beclornethasone dipropionate, and terbutaline sulphate), solvates and esters, including combinations of two or more thereof. Individual isomers such as, for example, R-salbutamol, may also be used. As will be appreciated, the pharmaceutical may comprise of one or more active ingredients, an example of which is flutiform, and may optionally be provided together with a suitable carrier, for example a liquid carrier. One or more surfactants may be included if desired.</p>
<p>The seals and gaskets of the valve may be formed from any suitable material having acceptable performance characteristics. Preferred examples include nitrile, EPDM and other thermoplastic elastomers, butyl and neoprene.</p>
<p>Other rigid components of the valve, such as the valve body, chamber body and valve stem may be formed, for example, from polyester, nylon, acetal or similar.</p>
<p>Alternative materials for the rigid components of the valve include stainless steel, ceramics and glass. These rigid components can be termed as non-sealing components', although it will be understood that the inner seal, outer seal or gasket may form a seal when abutting the so-called non-sealing components.</p>
<p>One or more components of the metering valve may have a layer of one or more polymerised monomers bonded to at least a portion thereof. Preferably the one or more monomers are selected from the group of materials comprising perfluoro-cyclohexarie, perfluoro-hexane, tetrafluoroethylene, trifluoroethylerie, vinylidene fluoride, vinylfluoride, fluoroethylene, fluoropropylene, a siloxane, a silazane, and a parylene.</p>
<p>In the following description and claims "inner" and "outer" are used to describe relative positions of components of the metering valve which are respectively further from or nearer to an outer end of valve stem, as shown in the Figures.</p>
<p>Embodiments of the present invention will now be described, by way of example only, with reference to the accompanying drawings, in which: Figure 1 is a cross-sectional view of a first exemplary metering valve for use with the method of the present invention; Figure 2 is a partial cross-sectional view of the metering valve of Figure 1 with certain internal components shown in perspective view; Figure 3 is a cross-sectional view of a second exemplary metering valve for use with the method of the present invention; Figure 4 is a partial cross-sectional view of the metering valve of Figure 3 with certain internal components shown in perspective view; Figure 5 is cross-sectional view through a third exemplary metering valve for use with the method of the present invention; and Figure 6 is a partial cross-sectional view of the metering valve of Figure 5 with certain internal components shown in perspective view.</p>
<p>In line with the present invention, one or more valve components, the chamber body, the valve body, the valve stem assembly, one or more seals (inner or outer seals), the gasket, the ferrule, and/or the spring are subjected to sterilisation means.</p>
<p>The sterilisatiori means can be radiation sterilisation, chemical sterilisation or heat sterilisation.</p>
<p>Radiation sterilisation (either electron or gamma) is particularly suited for certain plastics materials, such as polyester, to provide very good sterilisation.</p>
<p>Radiation sterilisation may be unsuitable for other plastics, for example polyacetal, owing to material reaction with the radiation. The gamma and electron radiation penetrate through the plastics material to provide sterilisation on outer and inner regions of the plastics material. Further, as penetration occurs, it is possible to sterilise assembled, or partially assembled valve components in this manner, which may otherwise have regions that are difficult to reach by non-penetrating sterilisation methods.</p>
<p>Heat sterilisation and chemical sterilisation are, generally, non-penetrating sterilisation when used with valve components which have tortuous cavities of small size.</p>
<p>Although it will be understood that heat will penetrate an object to some extent and ethylene oxide may pass through thin materials. As such, sterilisation with these methods involves maximising contact of the surfaces of objects with the sterilising medium. Typically, this involves surrounding the valve components in a steam or ethylene oxide environment for a suitable period of time to sterilise the valve components. These methods are also not suitable for all materials as some materials are adversely affected by the heat of the steam. Further, assembled objects having -10 -internal surfaces which are hard to reach require a much longer sterilisatiori time or cannot provide adequate sterilisation for the hard to reach areas.</p>
<p>Therefore, it will be understood by the skilled person that various sterilisation techniques can be used, although which one provides the best results must be assessed for the particular material properties of the valve components and the arrangement of valve components.</p>
<p>In a preferred embodiment, the non-sealing components are made from polyester. The valves shown in Figures 1 to 6 provide examples of suitable valve arrangements for use with the claimed method. These polyester components are subjected to either gamma radiation of electron radiation in order to sterilise them. This method provides good sterilisation as polyester is not adversely affected by gamma or electron radiation. Naturally, it will be understood that sterilisation may occur prior to assembly of the valve components, during assembly or subsequent to assembly.</p>
<p>In a further embodiment of the invention, a container may be sterilised also.</p>
<p>It will be understood by the person skilled in the art that the method of the present invention may be used with any valve suitable for use with aerosol dispensing apparatus. Accordingly, the exemplary metering valves shown in Figures 1 to 6 -and described below -are provided as examples of valve arrangements that may benefit from the claimed invention. However, the claimed method is equally applicable to other valve arrangements not specifically disclosed herein. For example, the method is at least applicable to non-metering valves and valve components.</p>
<p>-11 -As shown in Figures 1 and 2, the first exemplary metering valve 10, for use with the method of the present invention, includes an elongated valve stem assembly 11 which protrudes from and is axially slidable within a chamber body 12, the chamber body 12 and valve stem assembly 11 defining therebetween an annular metering chamber 13.</p>
<p>The chamber body 12 is located within a valve body 14 which is positioned within a pressurised container (aerosol dispensing apparatus) containing a product to be dispensed.</p>
<p>The metering valve 10 is held in position with respect to the container by means of a ferrule 15 which is crimped to the top of the container. Sealing between the valve body 14 and container is provided by an annular gasket 16. The ferrule 15 has an aperture 28 through which an outer section 19 of the valve stem assembly 11 protrudes.</p>
<p>A pair of seals 17, 18 of an elastomeric material extend radially between the valve stem assembly 11 and the chamber body 12. The "outer" seal 17 is radially compressed between the chamber body 12, valve stem assembly 11 and ferrule 15 so as to provide positive sealing contact to prevent leakage of the contents of the metering chamber 13 between the valve stem assembly 11 and the aperture 28. The compression is achieved by using a seal which provides an interference fit on the valve stem assembly 11 and/or by the crimping of the ferrule 15 onto the pressurised container during assembly. The "inner" seal 18 is located between chamber body 12 and valve body 14 to seal an "inner" end of the metering chamber 13 from the container contents when the valve is in a dispensing position.</p>
<p>The outer section 19 of the valve stem assembly 11 comprises the discharging end of the valve stem assembly 11 and protrudes from the ferrule 15. The outer section 19 -12 -comprises a hollow section 22 with an open upper end 9. The hollow section 22 is closed off within the valve by a solid mid-section 26 of the valve stem assembly 11. The hollow section 22 includes a discharge port 2]. extending radially through the side wall of valve stem assembly 11.</p>
<p>A radially-extending flange 20 is provided on the mid-section 26 of the valve stem assembly, located within the confines of the metering chamber 13.</p>
<p>An inner section 27 of the valve stem assembly 11 extends inwardly from the solid mid-section 26 and comprises a hollow section having a central passage 24 in the form of a bore with an open inner end 31 which communicates with an interior of the valve body 14. The inner section 27 has a stepped outer profile. An upper portion 27a of the inner section 27 has an outer diameter equal to the outer diameter of the solid mid-section 26. A lower portion 27b of the inner section 27 has a smaller outer diameter such that the inner section 27 undergoes a step change in diameter between the two portions 27a and 27b.</p>
<p>Two elongated slots 40 are formed in the upper portion 27a of the inner section 27. The slots 40 are orientated along the long axis of the valve stem assembly 11 and extend from the solid mid-section 26 to the step change in diameter of the inner section 27. The slots 40 extend radially through the thickness of the wall of the upper portion 27a allowing fluid communication between the central passage 24 and outside the valve stem assembly 11 via the slots 40.</p>
<p>The slots 40 are located diametrically opposite one another as best shown in Figure 2. The slots have a width of 1.00 mm and a length (along the axis of the valve stem assembly 11) of approximately 4.20 mm. The central passage 24 of the inner section 27 of the valve stem assembly 11 preferably -13 -has an internal diameter equal to the width of the slots 40, in the example shown 1.00 mm.</p>
<p>The valve stem assembly further comprises a stem base which is received on the end of the inner section 27.</p>
<p>The stem base 45 comprises a cylindrical portion 43 with a central bore 46 in which the inner portion 27b of the inner section 27 is received as a sliding fit. The stem base 45 further comprises a flange 44 having an upper face 47 which, on assembly of the valve, abuts a shoulder 51 formed at the step change in diameter of the inner section 27. Three projections 48 extend upwardly from the upper face 47 into proximity with the undersurface of the inner seal 18 and surround the upper portion 27a of the inner section 27.</p>
<p>Preferably, the distal ends of the projections are spaced from the underside of the inner seal 18 by between 0.3 and 0.5 mm when the valve stem 11 is in the non-dispensing position. Openings are located between the three projections 48 such that the top of the stem cap 45 has a castellated appearance. The openings allow unimpeded access for fluid flow into and out of the openings 40. The projections 48 restrain lateral movement of the upper portion 27. In addition, the projections 48 act to realign the inner seal 18 during actuation of the valve 10. During movement of the valve stem assembly 11 into the dispensing position there is a tendency for the inner seal 18 to be dragged inwards, out of the plane of the seal, due to the friction between the seal's inner diameter and the valve stem surface. This is a particular problem early in the life of a valve when the seal 18 is relatively new.</p>
<p>Uncorrected, this movement of the seal 18 has the ability over time and many actuations of the valve to create variations in the volume of the metering chamber 13 and -14 -hence the dose dispensed. The projections 48 alleviate the problem by contacting and pushing back the inner seal 18 on each movement of the valve stem assembly 11 into the non-dispensing position.</p>
<p>A spring 25 extends between the valve body 14 and an undersurface 49 of the flange 44 of the stem base 45 to bias the valve stem assembly 11 into the non-dispensing position as shown in Figure 1 in which the flange 20 is held in sealing contact with the outer seal 17.</p>
<p>In this position, the metering chamber 13 is sealed from the atmosphere by the outer seal 17, and can communicate with the bulk storage volume of the pressurised container to which the valve 10 is attached via the slots 40, open end 31 and the central passage 24. Fluid is prevented from by-passing the central passage 24 because of the sealing of the inner seal 18 against the valve stem assembly 11.</p>
<p>Thus, on inversion of the metering valve, so that the outer end 19 of the valve stem assembly 11 is lowermost, the metering chamber 13 will be rapidly charged with liquefied product to be dispensed. It will be noted that the liquefied product can pass from the bulk storage volume of the dispensing container into the valve body 14 via slits 50 formed in the inner part of the valve body 14 as best shown in Figure 2. On inversion, the metering chamber 13 will initially be filled by gaseous propellant vapour which must be displaced to allow the liquefied product to fill the chamber 13. Liquefied product can flow into the central passage 24 via the slots 40 and the open end 31. The combination of these points of entry for fluid flow has been found to produce excellent displacement of the propellant vapour in the metering chamber 13 and hence excellent -15 -filling performance. It is believed that the open end 31 of the central passage 24 creates a jet of fast moving liquid which mixes with and disturbs the liquid-vapour interface in the central passage 24 in the region of the junction between the slots 40 and the inner seal 18. This turbulent action of the jet is believed to decrease the flow restriction at this point leading to better displacement of the propellant vapour.</p>
<p>To actuate the metering valve the valve stem assembly 11 is depressed relative to the valve body 14 such that the valve stem assembly 11 slides axially relative to the chamber body 12. Upon depression of the valve stem assembly 11 the slots 40 slide relative to the inner seal 18 and are closed off by the inner seal 18 thereby isolating the metering chamber 13 from the contents of the valve body 14 and pressurised dispensing container. Upon further movement of the valve stem assembly 11 in the same direction into a dispensing position, the discharge port 21 passes through the outer seal 17 into communication with the metering chamber 13. In this dispensing position, the liquefied product in the metering chamber 13 rapidly boils off and is thus discharged to the atmosphere via the discharge port 21, hollow section 22 and outer end 19.</p>
<p>When the valve stem assembly 11 is released, the biasing of the return spring 25 causes the valve stem assembly 11 to return to its original, non-dispensing position. In normal use the apparatus is often turned upright for storage before the next actuation. The presence of the open end 31 and slots 40 allows for rapid draining of the metering chamber 13.</p>
<p>-16 -Figures 3 and 4 illustrate a second exemplary metering valve for use with the method of the present invention.</p>
<p>Like components to those described above with reference to the first embodiment have been marked with like numerals and will not be described fully here. Instead, the differences between the first and second embodiments will be described.</p>
<p>In the second exemplary metering valve, the inner section 27 of the valve stem assembly 11 is truncated. The inner section comprises two dependent, C-shaped legs 27a which extend inwardly from the mid-section 26 of the valve stem assembly. The closed-ended slots 40 of the first embodiment are modified to comprise open-ended slots 40 which extend from the distal end of the inner section 27 towards the mid-section 26. As before a central passage 24 is formed between the legs 27a of the inner section 27. A stem cap 45 is again provided. However, in this embodiment, the inner section 27 does not extend into the central bore 46 of the stem cap 45 but abuts against an upper face of the flange 44. The projections 48 prevent lateral movement of the inner section 27 and the stem cap 45. The bore 46 of the stem cap 45 forms a continuation 24a of the central passage 24 of the inner section 27. A lower end 31a of the bore 46 acts as the inner end of the central passage 24.</p>
<p>Operation of the valve is the same as the first example and the fluid flow on filling and draining of the metering chamber 13 is similar. Fluid enters the metering chamber via the central passage 24/24a and slots 40. As before it is believed that the jet of fluid flowing towards the inner seal 18 through the passages 24a and 24 acts to break up the liquid-vapour interface leading to better filling performance.</p>
<p>-17 -The construction of the valve stem assembly 11 of the second example has the added advantage that the moulding of the components is more straightforward than those of the first example. In particular the formation of the open-ended slots of the second example is simpler than that of the closed-ended slots of the first example.</p>
<p>Figures 5 and 6 illustrate a third exemplary metering valve for use with the method of the present invention. The valve 10' includes an elongated valve stem assembly 11' which protrudes from and is axially slidable within a chamber body 12', the chamber body 12' and valve stem assembly 11' defining therebetween an annular metering chamber 13'. The chamber body 12' is located within a valve body 14' which is positioned within a pressurised container containing a product to be dispensed. The metering valve 10' is held in position with respect to the container by means of a ferrule 15' which is crimped to the top of the container. Sealing between the valve body 14' and container is provided by an annular gasket 16'. The ferrule 15' has an aperture 28' through which an outer section 19' of the valve stem assembly 11' protrudes. A pair of seals 17', 18' of an elastomeric material extend radially between the valve stem assembly 11' and the chamber body 12'. The "outer" seal 17' is radiallycompressed between the chamber body 12', valve stem assembly 11' and ferrule 15' so as to provide positive sealing contact to prevent leakage of the contents of the metering chamber 13' between the valve stem assembly 11' and the aperture 28'. The compression is achieved by using a seal which provides an interference fit on the valve stem assembly 11' and/or by the crimping of the ferrule 15' onto the pressurised container during assembly.</p>
<p>-18 -The "inner" seal 18' is located between chamber body 12' and valve body 14' to seal an "inner" end of the metering chamber 13' from the container contents when the valve is in a dispensing position.</p>
<p>The valve stem assembly 11' comprises an upper portion 27' and a stem base 45' which is received on the end of the upper portion 27'. The stem base 45' comprises a cylindrical portion 13' with a central bore 46' in which a part of the upper portion 27' is received as a sliding fit.</p>
<p>An inner end of the upper portion 27' of the valve stem assembly 11' is provided with four longitudinally running flutes 60' which extend part way along the length of the upper portion 27' from the distal end of the upper portion 27'. The flutes 60' are separated from one another by ribs 61' and the flutes 60' are shallow enough for the upper portion 27' to comprise a solid core 62'. In the non-dispensing position shown in Figures 5 and 6 the flutes 60' provide fluid communication between the bulk storage product contained in the dispensing container to which the metering valve is attached and the metering chamber 13' since the flutes 60' bridge the inner seal 18' as best shown in Figure 6. Consequently flow into and out of the metering chamber in the non-dispensing position is possible. On actuation, the valve stem assembly 11' is depressed, moving the flutes 60' through the inner seal 18' so as to seal off the dispensing container bulk storage volume from the metering chamber 13'. Further depression moves an outlet port 21' of the valve stem assembly 11' into communication with the metering chamber 13' leading to dispensation of the dose of product contained in the metering chamber 13' Compared to capillary retention valves the flow path into and out of the metering chamber 13' has been greatly -19 -enlarged. Despite this it has been discovered that with this design of valve it is difficult to ensure that the metering chamber 13' is filled completely and consistently when the valve is inverted. In addition, it has been discovered that the draining of the metering chamber 13', when the apparatus is turned upright, is inconsistent and can leave product within the metering chamber 13' for appreciable periods of time.</p>
Claims (1)
- <p>-20 -CLAIMS: 1.) A method of sterilisation of valve componentscomprising: providing one or more valve components, which are suitable for use in aerosol dispensing apparatus; subjecting at least part of the one or more valve components to sterilisation means selected from one or more of: radiation sterilisation means; chemical sterilisation means; or heat sterilisation means.</p><p>2.) A method of sterilisation according to claim 1, wherein the one or more valve components comprise a chamber body, a valve body, a valve stem, one or more seals, a gasket, a ferrule, and/or a spring.</p><p>3.) A method of sterilisation according to claim 1 or claim 2, wherein the one or more valve components can be assembled to provide a metering valve.</p><p>4.) A method of sterilisation according to any preceding claim, wherein non-sealing components of the one or more valve components are subjected to the sterilisation means.</p><p>5.) A method of sterilisation according to any preceding claim, wherein the one or more valve components are made from a material comprising a plastics material.</p><p>6.) A method of sterilisation according to claim 5, wherein the one or more valve components are made from a material comprising polyester.</p><p>-21 - 7.) A method of sterilisation according to any preceding claim, wherein the radiation sterilisation means is gamma radiation.</p><p>8.) A method of sterilisation according to any one of claims 1 to 6, wherein the radiation sterilisation means is electron radiation.</p><p>9.) A method of sterilisation according to any preceding claim, wherein the chemical sterilisation means is gaseous chemical sterilisation means.</p><p>10.) A method of sterilisation according to claim 9, wherein the chemical sterilisation means is ethylene oxide.</p><p>11.) A method of sterilisation according to any preceding claim, wherein the heat sterilisation means is heating of the one or more valve components.</p><p>12.) A method of sterilisation according to claim 11, wherein the heat sterilisation means is steam.</p><p>13.) A method of sterilisation according to any preceding claim, wherein the sterilisation means comprises one or more of an autoclave, dry-heat sterilisation, ozone, bleach, glutaraldehyde, formaldehyde, ortho-phthalaldehyde, hydrogen peroxide, x-rays, subatomic particles, and/or UV (ultra violet) radiation.</p><p>-22 - 14.) A method of sterilisation according to any preceding claim, wherein the one or more valve components are un-assembled prior to sterilisation.</p><p>15.) A method of sterilisation according to any one of claims 1 to 13, wherein the one or more valve components are partially-assembled prior to sterilisation.</p><p>16.) A method of sterilisation according to any one of claims 1 to 13, wherein the one or more valve components are fully-assembled prior to sterilisation.</p><p>17.) A method of sterilisation according to any preceding claim, wherein the method comprises providing a container for subsequent location of a product to be dispensed and subjecting the container to sterilisation means.</p><p>18.) A method of sterilisation substantially as herein described, with reference to the accompanying drawings and</p><p>description.</p><p>19.) One or more valve components sterilised by the method of claims 1 to 18.</p><p>20.) A valve as produced by the method of claims 1 to 18.</p><p>21.) An aerosol dispensing apparatus including a valve or one or more valve components sterilised by the method of claims 1 to 18.</p><p>22.) A method of sterilisation of an aerosol dispensing apparatus wherein the apparatus comprises: -23 -one or more valve components; and a container for storing a product to be dispensed from the aeroso1 dispensing apparatus; wherein the method comprises subjecting at least part of the one or more valve components, and/or container to sterilisation means selected from one or more of: radiation sterilisation means; chemical sterilisation means; or heat sterilisation means.</p>
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0624421A GB2439402A (en) | 2006-12-06 | 2006-12-06 | Methods of sterilisation of aerosol valve components |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0624421A GB2439402A (en) | 2006-12-06 | 2006-12-06 | Methods of sterilisation of aerosol valve components |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0624421D0 GB0624421D0 (en) | 2007-01-17 |
GB2439402A true GB2439402A (en) | 2007-12-27 |
Family
ID=37711691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0624421A Withdrawn GB2439402A (en) | 2006-12-06 | 2006-12-06 | Methods of sterilisation of aerosol valve components |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2439402A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2470403A (en) * | 2009-05-21 | 2010-11-24 | Consort Medical Plc | Valve assembly with valve stem for use with an aerosol canister |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2216422A (en) * | 1988-03-24 | 1989-10-11 | Abplanalp Robert H | Sterilizing valved pressure containers |
EP0338670A2 (en) * | 1988-03-22 | 1989-10-25 | FISONS plc | Pharmaceutical Compositions |
DE3906891A1 (en) * | 1989-03-03 | 1990-09-06 | Ueberall Peter | Microbe-repelling piping |
US5137179A (en) * | 1990-02-15 | 1992-08-11 | Hans Stoffel | Containers and methods for preparing and manufacturing the same |
US5474099A (en) * | 1994-12-23 | 1995-12-12 | Vernay Laboratories, Inc. | Non-stick treatment for elastomeric slit valves |
US6123900A (en) * | 1993-10-28 | 2000-09-26 | Vellutato; Arthur L. | Method of sterilization |
US20020129858A1 (en) * | 2001-03-16 | 2002-09-19 | Colder Products Company | Connector apparatus and method of coupling bioprocessing equipment to a media source |
US20030124023A1 (en) * | 2001-12-21 | 2003-07-03 | Wilson Burgess | Method of sterilizing heart valves |
FR2835005A1 (en) * | 2002-01-24 | 2003-07-25 | Chavonnet Sa | Mixer tap, e.g. for hospital use, has bell-shaped base that can be disengaged from delivery pipe connector to allow tap to be decontaminated |
US20030205687A1 (en) * | 2002-05-03 | 2003-11-06 | Acist Medical Systems, Inc. | Gamma-stable high pressure stopcock |
JP2005001712A (en) * | 2003-06-11 | 2005-01-06 | Daizo:Kk | Aerosol container, aerosol product and method for producing the same |
-
2006
- 2006-12-06 GB GB0624421A patent/GB2439402A/en not_active Withdrawn
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0338670A2 (en) * | 1988-03-22 | 1989-10-25 | FISONS plc | Pharmaceutical Compositions |
GB2216422A (en) * | 1988-03-24 | 1989-10-11 | Abplanalp Robert H | Sterilizing valved pressure containers |
DE3906891A1 (en) * | 1989-03-03 | 1990-09-06 | Ueberall Peter | Microbe-repelling piping |
US5137179A (en) * | 1990-02-15 | 1992-08-11 | Hans Stoffel | Containers and methods for preparing and manufacturing the same |
US6123900A (en) * | 1993-10-28 | 2000-09-26 | Vellutato; Arthur L. | Method of sterilization |
US5474099A (en) * | 1994-12-23 | 1995-12-12 | Vernay Laboratories, Inc. | Non-stick treatment for elastomeric slit valves |
US20020129858A1 (en) * | 2001-03-16 | 2002-09-19 | Colder Products Company | Connector apparatus and method of coupling bioprocessing equipment to a media source |
US20030124023A1 (en) * | 2001-12-21 | 2003-07-03 | Wilson Burgess | Method of sterilizing heart valves |
FR2835005A1 (en) * | 2002-01-24 | 2003-07-25 | Chavonnet Sa | Mixer tap, e.g. for hospital use, has bell-shaped base that can be disengaged from delivery pipe connector to allow tap to be decontaminated |
US20030205687A1 (en) * | 2002-05-03 | 2003-11-06 | Acist Medical Systems, Inc. | Gamma-stable high pressure stopcock |
JP2005001712A (en) * | 2003-06-11 | 2005-01-06 | Daizo:Kk | Aerosol container, aerosol product and method for producing the same |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2470403A (en) * | 2009-05-21 | 2010-11-24 | Consort Medical Plc | Valve assembly with valve stem for use with an aerosol canister |
Also Published As
Publication number | Publication date |
---|---|
GB0624421D0 (en) | 2007-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7387121B2 (en) | Valve for aerosol container | |
EP2069217B1 (en) | Metering valve and dispensing apparatus | |
US6474513B2 (en) | Valve for aerosol container | |
US7959042B2 (en) | In metering valves for pressurised dispensing containers | |
US7793805B2 (en) | Metering valve | |
US20090065533A1 (en) | Dispensing apparatus | |
EP0999987B1 (en) | Aerosol container comprising a valve | |
US20080224082A1 (en) | Valves | |
GB2439402A (en) | Methods of sterilisation of aerosol valve components | |
GB2430188A (en) | Dispenser with valve stem made of ultra-high molecular weight polyethylene | |
CN100494010C (en) | metering valve | |
GB2401099A (en) | Improvements in valves for pressurised dispensing containers | |
GB2402667A (en) | Dispensing device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |